Rief Winfried
Psychotherapie Ambulanz, Philipps Universität Marburg, Gutenbergstraße 18, 35032, Marburg, Deutschland.
Nervenarzt. 2020 Aug;91(8):675-683. doi: 10.1007/s00115-020-00940-x.
There is substantial evidence that placebo and nocebo effects occur during treatment with antidepressants. A better understanding of the underlying mechanisms of these effects is necessary to optimize the outcome of treatment and to make clinical studies more sensitive.
Placebo and nocebo mechanisms were analyzed based on empirical studies and the results are summarized in a narrative review.
Clinical studies and also experimental mechanism-oriented studies underline the effects of placebo and nocebo mechanisms in the treatment with antidepressants.
The success of treatment in the use of antidepressants can be increased and the probability of side effects can be reduced by the effective use of placebo mechanisms and reduction of nocebo effects. The results emphasize the influence of clinician-patient interactions, the role of the treatment context and previous experiences with other treatments of the patient. Simultaneously, the results of this research field stimulate a new understanding of mental disorders, in particular depression and also provide points of reference for optimization of psychotherapeutic treatment.
有大量证据表明,在使用抗抑郁药治疗期间会出现安慰剂和反安慰剂效应。更好地理解这些效应的潜在机制对于优化治疗结果和提高临床研究的敏感性是必要的。
基于实证研究分析安慰剂和反安慰剂机制,并在叙述性综述中总结结果。
临床研究以及以实验机制为导向的研究都强调了安慰剂和反安慰剂机制在抗抑郁药治疗中的作用。
通过有效利用安慰剂机制和减少反安慰剂效应,可以提高抗抑郁药治疗的成功率,并降低副作用的发生率。结果强调了临床医生与患者互动的影响、治疗背景的作用以及患者既往其他治疗经历。同时,该研究领域的结果激发了对精神障碍,特别是抑郁症的新认识,也为优化心理治疗提供了参考依据。